![AbbVie Appoints Robert A. Michael as CEO](https://i-invdn-com.investing.com/news/World_News_8_150x108_S_1420026210.jpg)
Please try another search
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 37.96 | 37.96 | 28.2 | 28.2 |
Gross Profit | 21.49 | 21.49 | 13.54 | 13.54 |
Operating Income | 3.15 | 3.15 | -1.94 | -1.94 |
Net Income | 1.46 | 1.46 | -0.732 | -0.732 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 184.92 | 184.92 | 154.92 | 154.92 |
Total Liabilities | 109.11 | 109.11 | 82.37 | 82.37 |
Total Equity | 75.82 | 75.82 | 72.55 | 72.55 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -9.11 | -9.11 | 14.07 | 14.07 |
Cash From Investing Activities | -2.03 | -2.03 | -0.452 | -0.452 |
Cash From Financing Activities | -1.79 | -1.79 | -0.85 | -0.85 |
Net Change in Cash | -12.93 | -12.93 | 12.64 | 12.64 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review